Jiangsu Nhwa Pharmaceutical Hits Day Low of CNY 18.71 Amid Price Pressure

Jiangsu Nhwa Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock hitting an intraday low of CNY 18.71. The company reported a loss of 3.1% on June 30, 2026, contrasting with a slight gain of 0.5% in the China Shanghai Composite index during the same period. Over the past week, Jiangsu Nhwa's performance has been down by 1.63%, while it has seen a more significant drop of 7.59% over the last month. Year-to-date, the stock has decreased by 22.3%, and its performance over the past three years shows a decline of 39.18%. In comparison, the China Shanghai Composite has performed positively, with a 3.16% increase year-to-date and an impressive 27.87% rise over three years. Financial metrics indicate that the company has faced challenges, with a net profit of CNY 268.7 million reflecting a decrease of 36.65%. The return on equity stands at 12.80%, and the company maintains a dividend yield of 2.05%. Despite these figures, Jiangsu Nhwa continues to navigate a competitive landscape within the pharmaceuticals and biotechnology sector.